Dipl.-Ing. Dr. Thomas Mohr
Ries, A., Flehberger, D., Slany, A., Pirker, C., Mader, J. C., Mohr, T., Schelch, K., Sinn, K., Mosleh, B., Hoda, M. A., Dome, B., Dolznig, H., Krupitza, G., Müllauer, L., Gerner, C., Berger, W., & Grusch, M. (2023). Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. Journal of Experimental and Clinical Cancer Research, 42(1), [27]. https://doi.org/10.1186/s13046-022-02582-0
Ries, A., Slany, A., Pirker, C., Mader, J. C., Mejri, D., Mohr, T., Schelch, K., Flehberger, D., Maach, N., Hashim, M., Hoda, M. A., Dome, B., Krupitza, G., Berger, W., Gerner, C., Holzmann, K., & Grusch, M. (2023). Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells, 12(15), [2006]. https://doi.org/10.3390/cells12152006
Caban, M., Koblmueller, B., Groza, D., Schueffl, H. H., Terenzi, A., Tolios, A., Mohr, T., Mathuber, M., Kryeziu, K., Jaunecker, C., Pirker, C., Keppler, B. K., Berger, W., Kowol, C. R., & Heffeter, P. (2023). A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo. Cancer Letters, 565, [216237]. https://doi.org/10.1016/j.canlet.2023.216237
Soukup, R., Gerner, I., Mohr, T., Gueltekin, S., Grillari, J., & Jenner, F. (2023). Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. International Journal of Molecular Sciences, 24(13), [10857]. https://doi.org/10.3390/ijms241310857
Ertl, I. E., Brettner, R., Kronabitter, H., Mohr, T., Derdak, S., Jeitler, M., Bilban, M., Garstka, N., & Shariat, S. F. (2023). The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. Cells, 12(1), [124]. https://doi.org/10.3390/cells12010124
Mödl, B., Awad, M., Zwolanek, D., Scharf, I., Schwertner, K., Milovanovic, D., Moser, D., Schmidt, K., Pjevac, P., Hausmann, B., Krauß, D., Mohr, T., Svinka, J., Kenner, L., Casanova, E., Timelthaler, G., Sibilia, M., Krieger, S., & Eferl, R. (2023). Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. EMBO Reports. https://doi.org/10.15252/embr.202357084
Malik, B., Vokic, I., Mohr, T., Poppelaars, M., Holcmann, M., Novoszel, P., Timelthaler, G., Lendl, T., Krauss, D., Elling, U., Mildner, M., Penninger, J. M., Petzelbauer, P., Sibilia, M., & Csiszar, A. (2023). FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice. EMBO Molecular Medicine, 15(7), [e16758]. https://doi.org/10.15252/emmm.202216758
Janker, L., Schuster, D., Bortel, P., Hagn, G., Meier-Menches, S. M., Mohr, T., Mader, J. C., Slany, A., Bileck, A., Brunmair, J., Madl, C., Unger, L., Hennlich, B., Weitmayr, B., Del Favero, G., Pils, D., Pukrop, T., Pfisterer, N., Feichtenschlager, T., & Gerner, C. (2023). Multi-omics empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjad052
Moritsch, S., Moedl, B., Scharf, I., Janker, L., Zwolanek, D., Timelthaler, G., Casanova, E., Sibilia, M., Mohr, T., Kenner, L., Herndler-Brandstetter, D., Gerner, C., Mueller, M., Strobl, B., & Eferl, R. (2022). Tyk2 is a tumor suppressor in colorectal cancer. OncoImmunology, 11(1), [2127271]. https://doi.org/10.1080/2162402X.2022.2127271
Multi-Omics Readouts of Perturbation Studies are Determined by Memory Effects from Subculture
Lukas Skos (Vortragende*r), Patricia Bortel (Autor*in), Gerhard Hagn (Autor*in), Andrea Bileck (Autor*in), Verena Paulitschke (Autor*in), Philipp Paulitschke (Autor*in), Lion Gleiter (Autor*in), Thomas Mohr (Autor*in), Christopher Gerner (Autor*in) & Samuel Matthias Meier-Menches (Autor*in)
11 Mai 2023
Aktivität: Vorträge › Vortrag › Science to Science